Sunday, May 22, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Msn Obtains Us Fda Nod For Asenapine Sublingual Tablets

MSN gets US FDA nod for Asenapine Sublingual tablets

By Telangana Today
Published: Updated On - 06:13 PM, Sun - 7 March 21
Asenapine is indicated for the treatment of patients suffering from Schizophrenia and Bipolar disorder

Hyderabad: MSN Group (MSN) received final approval for its abbreviated new drug application (ANDA) for Asenapine Sublingual Tablets, in 5 mg strength, a generic for Saphris, with the US Food and Drug Administration. Asenapine is indicated for the treatment of patients suffering from Schizophrenia and Bipolar disorder.

MSN previously received final approval for 2.5mg and 10mg strengths of the same product. The product will be launched by its marketing partner Breckenridge Pharmaceutical.

As per industry sales data, Asenapine had annual sales of $239 million during the twelve months ending September 2020.

MSN has over 100 ANDAs and 375 US Active Drug Master Files (DMFs). MSN has nine active pharmaceutical ingredient and five finished dosage facilities in Hyderabad including one in the US.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • ANDA
  • Asenapine
  • Asenapine Sublingual Tablets
  • MSN

Related News

  • Three Hyderabad firms to make generic version of Pfizer’s Covid drug

  • MSN set to launch molnupiravir generic drug for Covid-19 treatment

  • MSN Group launches anti-epileptic drug for infants

  • Sun Pharma settles patent dispute with US Celgene Corporation

  • MSN Labs launches Posaconazole to treat black fungus

  • MSN Labs enters into licensing agreement with Lilly

Latest News

  • Ranil on the runway

    7 hours ago
  • Hyderabad: SHE Teams nab 79 including 23 minors for harassing women

    7 hours ago
  • HMWS&SB to issue water bills for consumers not availing new scheme

    8 hours ago
  • IPL 2022: Delhi Capitals lose by 5 wickets against Mumbai Indians

    8 hours ago
  • Ace physical test with ease

    8 hours ago
  • The essential components of an ECG

    8 hours ago
  • Telangana’s golden boy Ravi Kiran dreams of Paralympic medal

    8 hours ago
  • Hyderabadi teen making waves on OTT

    8 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam